HRV Pharma buys Germany clinical trial supplier Phatebo
In short
HRV Pharma said it bought Phatebo, a Germany-based clinical trial supplier. The deal is said to give HRV Pharma a licensed operating business in Germany and help it move into finished formulations.
This may broaden the company’s business, but the price, timing, and other deal details were not stated in the available reporting.
What the reporting says
HRV Pharma bought Germany-based clinical trial supplier Phatebo, according to the publisher-supplied summary. The deal is described as expanding the company into finished formulations with a licensed operating business in Germany. The available reporting does not state the purchase price, completion date, or integration plan, so those details remain unknown.
Why it matters
HRV Pharma bought Germany-based Phatebo, and the publisher-supplied summary says the deal expands it into finished formulations and gives it a licensed operating business in Germany. No purchase price, closing date, or regulatory detail was stated. The immediate effect is a broader footprint for HRV Pharma, but the financial impact is unknown.